Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ.
ΠΡΠΏΠ΅ΠΊΡΡ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΈΠΊΡΠΎΡΠ΄Π΅Ρ Π² Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ
Bonassi S., Znaor A., Ceppi M, Lando C., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Cebulska-Wasilewska A., Fabianova E., Fucic A., Hagmar L., Joksic G., Martelli A., Migliore L., Mirkova E., Scarfi M.R., Zijno A., Norppa H., Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ. ΠΡΠΏΠ΅ΠΊΡΡ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΈΠΊΡΠΎΡΠ΄Π΅Ρ Π² Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
1. Abou-Eisha A. Evaluation of cytogenetic and DNA damage induced by the antibacterial drug, trimethoprim // Toxicol. In Vitro. — 2006. — V. 20. — № 5. — Π . 601−607.
2. Andrianopoulos C., Stephanou G., Demopoulos N.A. Genotoxicity of hydrochlorothiazide in cultured human lymphocytes. I. Evaluation of chromosome delay and chromosome breakage // Environ. Mol. Mutagen. — 2006. — V. 47. — № 3. — Π . 169−178.
3. Baeyens A., Vandersickel V., Thierens H., Ridder L.D., Vral A. Effects of estradiol and progesterone on the variability of the micronucleus assay // Mutat. Res. — 2005. — V. 578. — № 1−2. — Π . 308−316.
4. Bajic V., Milicevic Z., Spremo-Potparevic B. A negative adaptive response is expressed in peripheral blood lymphocytes that are exposed to mitomycin C and cycloheximide // J. BUON.
— 2005. — V. 10. — № 1. — Π .111−117.
5. Beetstra S., Salisbury C., Turner J., Altree M., McKinnon R., Suthers G., Fenech M. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency // Carcinogenesis. — 2006. — V. 27. — № 3. — Π .517−524.
6. Bolognesi C., Martini F., Tognon M., Filiberti R., Neri M., Perrone E., Landini E., Canessa P.A., Ivaldi G.P., Betta P., Mutti L., Puntoni R. A molecular epidemiology case control study on pleural malignant mesothelioma // Cancer Epidemiol. Biomarkers Prev. — 2005. — V. 14. — № 7. — Π . 1741−1746.
7. Bonassi S., Znaor A., Ceppi M, Lando C., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Cebulska-Wasilewska A., Fabianova E., Fucic A., Hagmar L., Joksic G., Martelli A., Migliore L., Mirkova E., Scarfi M.R., Zijno A., Norppa H., Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans // Carcinogenesis. — 2007. — V. 28.. — № 3. — Π . 625−631.
8. Cai H.F., Cai F., Fan Z.P. Determination of the rate of micronucleus formation in lymphocytes in liver diseases and its clinical significance // Zhonghua Nei Ke Za Zhi.
— 1991. — V. 30. — № 5. — Π . 289−290, 318.
9. Cavallo D., Ursini C.L., Omodeo-Sale E., Iavicoli S. Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs // Mutat. Res. — 2007. — V. 628. — № 1. — Π . 11−18.
10. Celik M., Donbak L., Unal F., Yuzbasioglu D., Aksoy H., Yilmaz S. Cytogenetic damage in workers from a coal-fired power plant // Mutat. Res. — 2007. — V. 627. — № 2. — Π . 158−163.
11. Cemeli E., Marcos R., Anderson D. Genotoxic and antigenotoxic properties of selenium compounds in the in vitro micronucleus assay with human whole blood lymphocytes and tk6 lymphoblastoid cells // Scientific World Journal. — 2006. — № 6. — Π . 1202−1210.
12. Chen E., Lim M.S., Rosic-Kablar S., Liu J., Jolicoeur P., Dube I.D., Hough M.R. Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice // Oncogene. — 2006. — V. 18. — Π . 2575−2587.
13. Chieco-Bianchi L., Saggioro D., Del Mistro A., Montaldo A., Majone F., Levis A.G. Chromosome damage induced in cord blood T-lymphocytes infected in vitro by HTLV-I. // Leukemia. — 1988. — V. 2. — № 12. — Π . 223−232.
14. Djelic N., Spremo-Potparevic B., Djelic D. Mutagenic activity of estradiol evaluated by an in vitro micronucleus assay. Short communication // Acta. Biol. Hung.
— 2005. — V 56. — № 3−4. — Π . 403−406.
15. Efthimiou M., Andrianopoulos C., Stephanou G., Demopoulos N.A., Nikolaropoulos S.S. Aneugenic potential of the nitrogen mustard analogues melphalan, chlorambucil and p-N, N-bis (2-chloroethyl)aminophenylacetic acid in cell cultures in vitro // - 2007. — V. 617. — № 1−2. — Π . 125−137.
16. Fenech M., Neville S. Conversion of excision-repairable DNA lesions to micronuclei within one cell cycle in human lymphocytes // Environ Mol. Mutagen. — 1992. — V. 19. — № 1. — Π . 27−36.
17. Fimognari C., Berti F., Cantelli-Forti G., Hrelia P. Effect of sulforaphane on micronucleus induction in cultured human lymphocytes by four different mutagens // Environ Mol. Mutagen.
— 2005. — V. 46. — № 4. — Π . 260−267.
18. Fimognari C., Berti F., Nusse M., Cantelli-Fortii G., Hrelia P. In vitro anticancer activity of cyanidin-3-O-beta-glucopyranoside: effects on transformed and non-transformed T lymphocytes // Anticancer Res. — 2005. — V. 25. — № 4. — Π . 2837−2840.
19. Grujicic D., Milosevic Djordjevic O., Arsenijevic S, Marinkovic D. The effect of combined therapy with ritodrine, erythromycin and verapamil on the frequency of micronuclei in peripheral blood lymphocytes of pregnant women // Clin. Exp. Med. — 2007. — V. 7. — № 1. — Π . 11−15.
20. Guler E., Orta T., Gunebakan S., Utkusavas A., Kolusayin Ozar M.O. Can micronucleus technique predict the risk of lung cancer in smokers? // TuberkΡ Toraks. — 2005. — V. 53. — № 3. — Π . 225−230.
21. Hamurcu Z, Demirtas H, Ascioglu O, Donmez-Altuntas H, Aktas E. Micronucleus evaluation in mitogen-stimulated lymphocytes of PUVA treated patients // Tohoku J. Exp. Med. — 2002. — V. 198. — № 1. — Π . 11−21.
22. Hamurcu Z., Donmez-Altuntas H., Borlu M., Demirtas H., Ascioslu O. Micronucleus frequency in the oral mucosa and lymphocytes of patients with Behcet’s disease // Clin/ Exp/ Dermatol. — 2005. — V. 30. — № 5. — Π . 565−569.